BIOATLA, INC. Payments of Stock Issuance Costs
BIOATLA, INC. (BCAB) reported Payments of Stock Issuance Costs of $3.32 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-03-26
- BIOATLA, INC. payments of stock issuance costs for fiscal 2022 was $3.32M, a 17.19% decline from fiscal 2021.
- BIOATLA, INC. payments of stock issuance costs for fiscal 2021 was $4.01M, a 78.95% decline from fiscal 2020.
- BIOATLA, INC. payments of stock issuance costs for fiscal 2020 was $19.03M.
| Period end | Payments of Stock Issuance Costs 12 month |
|---|---|
| 2022-12-31 | $3.32M 10-K · filed 2024-03-26 |
| 2021-12-31 | $4.01M 10-K · filed 2023-03-23 |
| 2020-12-31 | $19.03M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |